Prana Biotechnology Limited (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

PRAN 1.89 +0.15 (8.62%)
price chart
Why Prana Biotech's & Momenta Pharma's Stock Prices Fell Yesterday
3. prana-biotechnology-pran-momenta-pharmaceutical-mnta-news-why-. Biotech stocks took a strong hit yesterday, with Prana Biotechnology Limited (ADR) (PRAN) falling over 70% and Momenta Pharmaceuticals, Inc. (MNTA) sliding over 16%. Bidness Etc ...
Prana collapses after trial fails  Seeking Alpha
Volume Alert: Prana Biotechnology Limited (ADR) (NASDAQ:PRAN), Samson ...  Market News Call
Related articles »  
Prana Biotechnology Is Still A Short After Recent Alzheimer's Failure
Prana still is a good short candidate, because the PBT2 compound has failed to produce substantial efficacy in two Phase II trials.
Prana Biotechnology Limited (ADR) (PRAN) news: Prana Biotechnology - A ...
One company in particular, Prana Biotechnology (PRAN), is well-positioned to address this market with their lead drug, and in a realistic but optimistic scenario, the share price could ducuple (increase by 10 times) by the end of the month.
News Recap � Prana Biotechnology Limited (ADR) (NASDAQ:PRAN), Oi SA ...
Las Vegas, NV - April 17, 2014 - (TechSonian) - Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) reported that its Phase 2 REACH2HD clinical trial investigating PBT2 as a cure for Huntington disease met its primary safety endpoint and achieved ...
Micro cap Losers: ReneSola Ltd. (NYSE:SOL), Prana Biotechnology Limited ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) shares fell -7.99% in last trading session and ended the day on $1.74.
Trader's Buzzers - CEL-SCI Corporation, (CVM), Rexahn Pharmaceuticals ...  Techsonian (press release)
Related articles »  
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) Stops Erosion In Share ...
Dallas, Texas 04/09/2014 (FINANCIALSTRENDS) - Stock of Australia based drug maker Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) have posted modest recovery during trading yesterday, after receiving a shellacking last week, when it share price ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN): The Research Programs ...  USA Stock Report
Notable Movers: Prana Biotechnology Limited (ADR) (PRAN), Cincinnati Bell ...  Techsonian (press release)
Related articles »  
Bearish Stocks: MannKind Corporation (NASDAQ:MNKD), Prana Biotechnology ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) on Mar. 31 released the top line results of the 12-month Phase II Imaging trial in Alzheimer's Disease (�IMAGINE� Trial), based on draft results.
What's Hurting These 3 Stocks? � Prana Biotechnology Limited (ADR ...  Markets Emerging
Related articles »  
5 Heavy Selloffs: Prana Biotechnology Limited (ADR) (PRAN), Liquidity Services ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) lost another 17.86% following a 71.60% fall on Monday after the Australian drug developer said its most advanced potential treatment failed to meet the main goal in a study of patients with Alzheimer's ...
Related articles »  
Notable Movers: Glu Mobile Inc. (NASDAQ:GLUU), Prana Biotechnology Limited ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN), has reported the top line results of the 12-month Phase II Imaging trial in Alzheimer's Disease, based on draft results.
Related articles »  
Drug Losers: Prana Biotechnology Limited (NASDAQ:PRAN), Orexigen ...
Stock of Australia based drug maker Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) have posted modest recovery during trading yesterday, after receiving a shellacking last week, when it share price was down by close to 77 percent.
Related articles »